Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1961 2
1962 4
1963 3
1964 2
1965 2
1966 5
1967 5
1968 7
1969 2
1970 5
1971 3
1972 5
1973 4
1974 8
1975 7
1976 4
1977 2
1978 12
1979 9
1980 11
1981 10
1982 15
1983 17
1984 12
1985 7
1986 14
1987 15
1988 17
1989 24
1990 20
1991 18
1992 23
1993 23
1994 26
1995 33
1996 33
1997 37
1998 27
1999 36
2000 27
2001 43
2002 33
2003 36
2004 37
2005 51
2006 40
2007 31
2008 53
2009 39
2010 47
2011 62
2012 78
2013 80
2014 85
2015 85
2016 85
2017 90
2018 99
2019 94
2020 109
2021 129
2022 87
2023 25
Text availability
Article attribute
Article type
Publication date

Search Results

1,846 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Oki R, Izumi Y, Fujita K, Miyamoto R, Nodera H, Sato Y, Sakaguchi S, Nokihara H, Kanai K, Tsunemi T, Hattori N, Hatanaka Y, Sonoo M, Atsuta N, Sobue G, Shimizu T, Shibuya K, Ikeda K, Kano O, Nishinaka K, Kojima Y, Oda M, Komai K, Kikuchi H, Kohara N, Urushitani M, Nakayama Y, Ito H, Nagai M, Nishiyama K, Kuzume D, Shimohama S, Shimohata T, Abe K, Ishihara T, Onodera O, Isose S, Araki N, Morita M, Noda K, Toda T, Maruyama H, Furuya H, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R; Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS (JETALS) Collaborators. Oki R, et al. Among authors: maruyama h. JAMA Neurol. 2022 Jun 1;79(6):575-583. doi: 10.1001/jamaneurol.2022.0901. JAMA Neurol. 2022. PMID: 35532908 Clinical Trial.
Paragonimus and paragonimiasis in Asia: An update.
Yoshida A, Doanh PN, Maruyama H. Yoshida A, et al. Among authors: maruyama h. Acta Trop. 2019 Nov;199:105074. doi: 10.1016/j.actatropica.2019.105074. Epub 2019 Jul 8. Acta Trop. 2019. PMID: 31295431 Review.
Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial.
Tahara M, Oeda T, Okada K, Kiriyama T, Ochi K, Maruyama H, Fukaura H, Nomura K, Shimizu Y, Mori M, Nakashima I, Misu T, Umemura A, Yamamoto K, Sawada H. Tahara M, et al. Among authors: maruyama h. Lancet Neurol. 2020 Apr;19(4):298-306. doi: 10.1016/S1474-4422(20)30066-1. Epub 2020 Mar 18. Lancet Neurol. 2020. PMID: 32199095 Clinical Trial.
Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases.
Fang C, An J, Bruno A, Cai X, Fan J, Fujimoto J, Golfieri R, Hao X, Jiang H, Jiao LR, Kulkarni AV, Lang H, Lesmana CRA, Li Q, Liu L, Liu Y, Lau W, Lu Q, Man K, Maruyama H, Mosconi C, Örmeci N, Pavlides M, Rezende G, Sohn JH, Treeprasertsuk S, Vilgrain V, Wen H, Wen S, Quan X, Ximenes R, Yang Y, Zhang B, Zhang W, Zhang P, Zhang S, Qi X. Fang C, et al. Among authors: maruyama h. Hepatol Int. 2020 Jul;14(4):437-453. doi: 10.1007/s12072-020-10052-y. Epub 2020 Jul 7. Hepatol Int. 2020. PMID: 32638296 Free PMC article.
Drug-Related Pneumonitis Induced by Osimertinib as First-Line Treatment for Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Real-World Setting.
Sato Y, Sumikawa H, Shibaki R, Morimoto T, Sakata Y, Oya Y, Tamiya M, Suzuki H, Matsumoto H, Yokoi T, Hashimoto K, Kobe H, Hino A, Inaba M, Tsukita Y, Ikeda H, Arai D, Maruyama H, Hara S, Tsumura S, Sakata S, Fujimoto D. Sato Y, et al. Among authors: maruyama h. Chest. 2022 Nov;162(5):1188-1198. doi: 10.1016/j.chest.2022.05.035. Epub 2022 Jun 1. Chest. 2022. PMID: 35661746
Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation-positive non-small-cell lung cancer in a real-world setting (OSI-FACT).
Sakata Y, Sakata S, Oya Y, Tamiya M, Suzuki H, Shibaki R, Okada A, Kobe H, Matsumoto H, Yokoi T, Sato Y, Uenami T, Saito G, Tsukita Y, Inaba M, Ikeda H, Arai D, Maruyama H, Hara S, Tsumura S, Morinaga J, Sakagami T. Sakata Y, et al. Among authors: maruyama h. Eur J Cancer. 2021 Dec;159:144-153. doi: 10.1016/j.ejca.2021.09.041. Epub 2021 Nov 5. Eur J Cancer. 2021. PMID: 34749119
Reply.
Sarin SK, Choudhury A, Philips CA, Kamath P, Maruyama H, Valla D. Sarin SK, et al. Among authors: maruyama h. Gastroenterology. 2017 Apr;152(5):1247-1248. doi: 10.1053/j.gastro.2017.03.003. Epub 2017 Mar 6. Gastroenterology. 2017. PMID: 28268095 No abstract available.
Artisanry and ultrasound: a salty humor.
Maruyama H. Maruyama H. J Med Ultrason (2001). 2022 Jul;49(3):319-320. doi: 10.1007/s10396-022-01237-z. Epub 2022 Aug 11. J Med Ultrason (2001). 2022. PMID: 35951176 No abstract available.
Randomized Controlled Trial of High-Flow Nasal Cannula in Preterm Infants After Extubation.
Uchiyama A, Okazaki K, Kondo M, Oka S, Motojima Y, Namba F, Nagano N, Yoshikawa K, Kayama K, Kobayashi A, Soeno Y, Numata O, Suenaga H, Imai K, Maruyama H, Fujinaga H, Furuya H, Ito Y; NON-INVASIVE PROCEDURE FOR PREMATURE NEONATES (NIPPN) STUDY GROUP. Uchiyama A, et al. Among authors: maruyama h. Pediatrics. 2020 Dec;146(6):e20201101. doi: 10.1542/peds.2020-1101. Pediatrics. 2020. PMID: 33214331 Clinical Trial.
1,846 results